A 70-year-old man with hypertension and type 2 diabetes has been diagnosed with nonvalvular atrial fibrillation. His CHA2DS2-VASc score is 3. He has stage 4 chronic kidney disease with eGFR 20 mL/min/1.73 m2 and no mechanical valves. Which is the most appropriate anticoagulation strategy for stroke prevention?